Lv3
210 积分 2021-04-12 加入
Comprehensive analysis of kinase inhibitor selectivity
3个月前
已完结
Development of bifunctional anti-PD-L1 antibody MMAE conjugate with cytotoxicity and immunostimulation
3个月前
已完结
Consistent and Selective Expression of the Discoidin Domain Receptor-1 Tyrosine Kinase in Human Brain Tumors
3个月前
已完结
Comprehensive analysis of kinase inhibitor selectivity
6个月前
已完结
ASP3082, a First-in-class novel KRAS G12D degrader, exhibits remarkable anti-tumor activity in KRAS G12D mutated cancer models
6个月前
已关闭
A first-in-human study of the fibroblast activation protein–targeted, 4-1BB agonist RO7122290 in patients with advanced solid tumors
7个月前
已完结
Chemistries of bifunctional PROTAC degraders
7个月前
已完结
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
8个月前
已完结
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
10个月前
已完结
T cell receptor/CD3-signaling induces death by apoptosis in human T cell receptor gamma delta + T cells
1年前
已完结
皖公网安备34019202002308
